BMI requirements and off-label use Traditional semaglutide prescribing guidelines follow FDA approval criteria, which typically need: A BMI of 30 or higher (classified as obese), or A BMI of 27 or higher (classified as overweight) with at least one weight-related condition such as high blood pressure, elevated cholesterol, or type 2 diabetes Edens licensed providers follow standard guidelines but may consider individual factors beyond basic BMI cutoffs when its clinically appropriate
Your immune system is constantly fighting off invaders, and it needs all the support it can get
Nearly identical calories
Two things follow from that, and both matter
Is there a bacterial overload
The 2025 IV pilot (Lee & Burgess, n=2) found no changes in cardiac, hepatic, renal, thyroid, or glucose markers: but this was n=2 over 2 days, not sustained community-use dosing